Oklo Inc. announced on November 14, 2024, that it has signed a letter of intent to acquire Atomic Alchemy Inc., a U.S.-based company specializing in radioisotope production. The proposed acquisition is valued at $25 million in an all-stock transaction.
This strategic move aims to leverage Oklo’s fast reactor and fuel recycling technologies, which produce valuable co-products such as radioisotopes. The radioisotope market is projected to exceed $55.7 billion by 2026, with demand expected to increase significantly.
The acquisition is expected to have minimal immediate impact on Oklo’s operating cost structure and its previously announced 2024 outlook. Oklo intends to establish a resilient, U.S.-based radioisotope supply chain to meet essential demands across healthcare, industry, research, and defense.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.